Shanghai Serum Bio-Technology Co., Ltd. (SHSE: 688163)
Health Care · Biotechnology · CN
CN¥34.87
-12.83% today · +53.0% 1Y
Shanghai Serum Bio-Technology Co., Ltd. (SHSE: 688163) operates in the Biotechnology industry within the Health Care sector. The company is valued at $563.39M.
Over the last twelve months the share price has gained 53.0%, trading between 21.20 and 52.88.
Tweenvest scores Shanghai Serum Bio-Technology Co., Ltd. across four factors: quality 72/100, value 7/100, growth 26/100, dividend 49/100. Its strongest factor is quality.
688163 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $563.39M
- Revenue (TTM)
- $29.38M
- P/E
- 68.47
- EPS
- 0.51
- Dividend yield
- 1.09%
- Beta (5Y)
- 0.60
- 52-week high
- CN¥52.88
- 52-week low
- CN¥21.20
- Avg volume (3M)
- —
- Shares outstanding
- 108.22M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Blau Farmacêutica S.A.BOVESPA: BLAU3 | $584.71M | R$12.61 | +16.54% |
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $580.91M | CN¥11.79 | -5.07% |
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $575.67M | CN¥6.14 | -2.07% |
| Pharmicell Co., Ltd.KOSE: A005690 | $573.98M | ₩12,860.00 | +3.71% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $561.38M | CN¥5.73 | -0.87% |
| Zhejiang Orient Gene Biotech Co., LtdSHSE: 688298 | $557.20M | CN¥19.50 | +0.67% |
| DBV Technologies S.A.ENXTPA: DBV | $555.98M | €1.68 | -11.87% |
| Jacobio Pharmaceuticals Group Co., Ltd.SEHK: 1167 | $555.24M | HK$5.57 | -7.40% |
Figures last refreshed Oct 11, 2026.